Government to proceed with review of generic drugs' filing under KORUS FTA

Published: 2007-05-15 06:59:00

Updated: 2007-05-15 06:59:00

The government will continue to review the license application of a local pharmaceutical firm, even though the U.S. company that produced the original drug file a lawsuit over patent infringement under the free trade agreement between Korea and United States, according to an official of the healt...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK